CAS: 1620401-82-2 - UNC0379
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]- REF: AN-AG001SNWCAS: 1620401-82-2 | 98+% | 592,00 €~593,00 € | Mer 08 Mag 24 |
 | UNC0379 REF: TM-T1841CAS: 1620401-82-2 | 99.97% | 56,00 €~352,00 € | Mer 15 Mag 24 |
 | UNC 0379 REF: 3D-FU137732CAS: 1620401-82-2 | Min. 95% | 114,00 €~298,00 € | Mar 21 Mag 24 |
![4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-](https://static.cymitquimica.com/products/AN/thumb/AG001SNW.jpg)
4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-
CAS:1620401-82-2
Formula:
C23H35N5O2
Purezza:
98+%
Colore e forma:
Solid
Peso molecolare:
413.5563
Ref: AN-AG001SNW
| 100mg | 592,00 € | |
| 250mg | 593,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 08 Maggio 2024
UNC0379
CAS:1620401-82-2
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Formula:
C23H35N5O2
Purezza:
99.97%
Colore e forma:
Solid
Peso molecolare:
413.56
Ref: TM-T1841
| 5mg | 56,00 € | |
| 10mg | 91,00 € | |
| 25mg | 147,00 € | |
| 50mg | 236,00 € | |
| 100mg | 352,00 € | |
| 1ml*10 (DMSO) | 62,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 15 Maggio 2024
UNC 0379
CAS:1620401-82-2
Inhibitor of the histone methyltransferase SETD8 that supresses methylation of the K20 residue in histone …
Formula:
C23H35N5O2
Purezza:
Min. 95%
Colore e forma:
Solid
Peso molecolare:
413.56 g/mol
Ref: 3D-FU137732
| 10mg | 114,00 € | |
| 50mg | 298,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Maggio 2024
